Page last updated: 2024-08-24

simendan and cyclic gmp

simendan has been researched along with cyclic gmp in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Edes, I; Kiss, E; Kitada, Y; Kranias, EG; Papp, JG; Powers, FM; Solaro, RJ1
Du Toit, EF; McCarthy, J; Muller, CA; Opie, LH1
Maihöfer, NA; Martin, C; Rieg, AD; Rossaint, R; Uhlig, S; Verjans, E1
Andreadou, I; Chavdoula, E; Cokkinos, DV; Davos, CH; Efentakis, P; Farmakis, D; Gioti, K; Iliodromitis, EK; Klinakis, A; Kostomitsopoulos, N; Papapetropoulos, A; Sanoudou, D; Sigala, F; Suter, T; Tasouli, A; Tenta, R; Varela, A; Wenzel, P1

Other Studies

4 other study(ies) available for simendan and cyclic gmp

ArticleYear
Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
    Circulation research, 1995, Volume: 77, Issue:1

    Topics: Analysis of Variance; Animals; Calcium; Calcium-Binding Proteins; Cardiotonic Agents; Carrier Proteins; Cyclic AMP; Cyclic GMP; Electrophoresis, Polyacrylamide Gel; Guinea Pigs; Heart; Hydrazones; In Vitro Techniques; Myocardial Contraction; Myocardium; Myofibrils; Perfusion; Phosphorylation; Pyridazines; Sarcoplasmic Reticulum; Simendan; Troponin; Troponin C; Troponin I; Ventricular Function, Left

1995
Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2

    Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Agonists; Calcium Channel Blockers; Cyclic AMP; Cyclic GMP; Dobutamine; Glyburide; Guinea Pigs; Heart; Hydrazones; In Vitro Techniques; L-Lactate Dehydrogenase; Lactic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nucleotides, Cyclic; Phosphocreatine; Pyridazines; Simendan; Stereoisomerism

1999
Levosimendan Relaxes Pulmonary Arteries and Veins in Precision-Cut Lung Slices - The Role of KATP-Channels, cAMP and cGMP.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Animals; Culture Media; Cyclic AMP; Cyclic GMP; Female; Guinea Pigs; Hydrazones; KATP Channels; Lung; Pulmonary Artery; Pyridazines; Simendan; Vasodilation

2013
Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
    Cardiovascular research, 2020, 03-01, Volume: 116, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Calcium Signaling; Calcium-Binding Proteins; Cardiotoxicity; Cardiovascular Agents; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart Diseases; Male; Mammary Neoplasms, Experimental; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Rats, Wistar; Simendan; Time Factors

2020